Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 7 of 12 for:    gadoteridol

Meningeal Inflammation on 7T MRI as a Tool for Measuring and Predicting Ocrelizumab Response in Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03396822
Recruitment Status : Recruiting
First Posted : January 11, 2018
Last Update Posted : October 23, 2018
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Daniel Harrison, University of Maryland

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 2020
  Estimated Study Completion Date : January 2021